DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Emactuzumab
Emactuzumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Roche/Genentech Managed RG7986 ADC R/R NHL CHU Chugai Managed IONIS IONIS Managed 74 Status As of January 28, 2016 PRO Proximagen Managed
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Tanibirumab (CUI C3490677) Add to Cart
2017 Immuno-Oncology Medicines in Development
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
The Two Tontti Tudiul Lui Hi Ha Unit
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
Irp180426-A.Pdf
Ep 3178848 A1
The Current Landscape of Antibody-Based Therapies in Solid
KOL Event & Corporate Update
Roche Pharma Research & Early Development) Gred (Genentech Research & Early Development)
NSCLC (Update) • Cotellic + Zelboraf: Phase III 1L Melanoma (Cobrim), Overall Survival
(12) Patent Application Publication (10) Pub. No.: US 2015/0307617 A1 DU Et Al
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
Top View
CELLECTIS : Super Mario Car-T
List of Abbreviations
2018 Medicines in Development for Cancer
Immune Infiltrates in Breast Cancer: Recent Updates and Clinical
(INN) for Biological and Biotechnological Substances
Structured Immuno-Oncology Combination Strategies to Maximize Efficacy
Multifunctional Receptor-Targeting Antibodies for Cancer Therapy
The State-Of-The-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Next Generation of Immune Checkpoint Inhibitors and Beyond Julian A
Phase Ib Study of Anti-CSF-1R Antibody Emactuzumab In
Oncology Drugs in the Pipeline
A Review of Pre-Surgical Immunotherapy in HNSCC Margaret Stafford and John Kaczmar*
Tumor-Associated Macrophages in Breast Cancer Qiu, Si-Qi; Waaijer, Stijn J
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency
WO 2016/200835 Al 15 December 2016 (15.12.2016) P O P C T
Antibody News You Should Know July 1 - 15, 2020
Anti-Alphavbeta3 Monoclonal Antibody EMD 525797 (CUI C2830088) Add to Cart
New Insights Into Oral Squamous Cell Carcinoma: from Clinical Aspects to Molecular Tumorigenesis
(INN) for Biological and Biotechnological Substances
Cancer Immunotherapy Pipeline Overview
Industry Shows Increased Appetite for Macrophage Biology
Investor Presentation6 MB
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Tumor-Associated Macrophages in Tumor Metastasis: Biological Roles and Clinical Therapeutic Applications Yuxin Lin1, Jianxin Xu1* and Huiyin Lan2,3*